Post by
Mbxwatcher on Jun 06, 2024 1:32pm
Analysis
One thing I know for absolute certain:
I would be very happy to trade at .75 while we wait for the launch of Kinlytic.
At them moment i dont see the catalyst for that leap but who knows what else they may have up their sleeve.....
Comment by
wizzdumb on Jun 06, 2024 1:42pm
Agree. I'm surprised we haven't heard of a VTM replacement yet......lots of teases, but nothing concrete yet.
Comment by
Mbxwatcher on Jun 06, 2024 1:44pm
To me thats the only game changer in the very short term.......would love to see something on VTM
Comment by
rjc7 on Jun 06, 2024 3:50pm
I'm waiting for something totally out of left field that nobody was expecting. They do hold their cards close to their chest.
Comment by
wizzdumb on Jun 06, 2024 8:23pm
That's for sure, almost to their detriment.
Comment by
Method on Jun 08, 2024 5:26pm
Is there an obvious buyer for Microbix? What are the precedent transaction multiples? A buyer could pay out Kinlytic as a CVR if they don't want to pay up for it. None of the analysts attribute a lot of value for Kinlytic and I struggle to understand why except conservatism. Perhaps that just means I'm too optimistic on success and revenue ramp.
Comment by
Method on Jun 10, 2024 6:15pm
I think it's hard for a customer to buy the QAPs business. Probably needs to be another supplier otherwise there is too much risk of losing business. Any other ideas?
Comment by
mercedesman on Jun 10, 2024 10:03pm
Vertical integration happens all the time. Mainly to secure a steady source of supply. But if you get another revenue stream for the future as a bonus, why not? Not saying it will happen, but it's always a real possibility.
Comment by
RICHOFFMBX on Jun 10, 2024 5:43pm
Agreed. Some good news is that there's been more volume on the buy side of things for the last few weeks. Nobody seems to be jumping at the bid still - a lot of patience and restraint, but a marked improvement over the last 2 months for the time being, at least.